APA (7th ed.) Citation

Huang, M., Huang, G., Pearson, J. M., Gill, S., Holloway, R., Moroney, J., . . . Slomovitz, B. (2026). GOG-3039: A phase II trial of abemaciclib plus letrozole in recurrent or persistent endometrioid endometrial carcinoma (NCT04393285). Gynecologic Oncology, 208, S31. https://doi.org/10.1016/j.ygyno.2026.01.053

Chicago Style (17th ed.) Citation

Huang, Marilyn, et al. "GOG-3039: A Phase II Trial of Abemaciclib Plus Letrozole in Recurrent or Persistent Endometrioid Endometrial Carcinoma (NCT04393285)." Gynecologic Oncology 208 (2026): S31. https://doi.org/10.1016/j.ygyno.2026.01.053.

MLA (9th ed.) Citation

Huang, Marilyn, et al. "GOG-3039: A Phase II Trial of Abemaciclib Plus Letrozole in Recurrent or Persistent Endometrioid Endometrial Carcinoma (NCT04393285)." Gynecologic Oncology, vol. 208, 2026, p. S31, https://doi.org/10.1016/j.ygyno.2026.01.053.